IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 196 filers reported holding IMPAX LABORATORIES INC in Q3 2015. The put-call ratio across all filers is 2.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $243,000 | 0.0% | 13,100 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $243,000 | +14.6% | 13,100 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $212,000 | +27.7% | 13,100 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $166,000 | -8.3% | 13,100 | -7.7% | 0.00% | 0.0% |
| Q4 2016 | $181,000 | -41.4% | 14,200 | +8.4% | 0.00% | -33.3% |
| Q3 2016 | $309,000 | -19.1% | 13,100 | 0.0% | 0.00% | -25.0% |
| Q2 2016 | $382,000 | -67.9% | 13,100 | -64.4% | 0.00% | -71.4% |
| Q1 2016 | $1,189,000 | -25.9% | 36,800 | 0.0% | 0.01% | -22.2% |
| Q4 2015 | $1,604,000 | +26.2% | 36,800 | +1.9% | 0.02% | +12.5% |
| Q3 2015 | $1,271,000 | -20.2% | 36,100 | +4.0% | 0.02% | -15.8% |
| Q2 2015 | $1,593,000 | +1.8% | 34,700 | +3.9% | 0.02% | -5.0% |
| Q1 2015 | $1,565,000 | +29.0% | 33,400 | -11.9% | 0.02% | +33.3% |
| Q4 2014 | $1,213,000 | +23.5% | 37,900 | -8.5% | 0.02% | +15.4% |
| Q3 2014 | $982,000 | -18.6% | 41,400 | +3.0% | 0.01% | -27.8% |
| Q2 2014 | $1,206,000 | +5.0% | 40,200 | -7.6% | 0.02% | 0.0% |
| Q1 2014 | $1,149,000 | +18.1% | 43,500 | +11.0% | 0.02% | +12.5% |
| Q4 2013 | $973,000 | +24.3% | 39,200 | +2.6% | 0.02% | +14.3% |
| Q3 2013 | $783,000 | – | 38,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |